(RAMP) Liveramp Holdings - Overview
Stock: Data Collaboration, Identity Resolution, Measurement, Activation
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 40.1% |
| Relative Tail Risk | -9.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.78 |
| Alpha | -49.97 |
| Character TTM | |
|---|---|
| Beta | 1.088 |
| Beta Downside | 0.783 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.19% |
| CAGR/Max DD | -0.03 |
Description: RAMP Liveramp Holdings January 13, 2026
LiveRamp Holdings, Inc. (NYSE:RAMP) runs a privacy-centric data-collaboration platform that helps enterprises create a unified, people-based view of customers for marketing, measurement, and analytics. The suite includes identity resolution, data activation, and a marketplace for third-party data, serving marketers, agencies, publishers, and technology partners across sectors such as financial services, retail, telecom, and CPG.
Key recent metrics (FY 2023): revenue of approximately **$1.5 billion**, up **~10 % YoY**, with an operating margin of **~14 %** and a **free cash flow conversion of 85 %**. The company’s growth is tied to two macro drivers: (1) the continued shift of ad spend toward addressable, data-driven campaigns, and (2) tightening privacy regulations (e.g., GDPR, CCPA) that increase demand for consent-compliant identity solutions.
LiveRamp’s competitive positioning rests on its extensive data-on-ramp ecosystem-over **500 million** anonymized consumer IDs and integrations with more than **2,000** marketing technology platforms-providing network effects that are difficult for new entrants to replicate.
Given the sector’s reliance on ad-tech spend cycles and regulatory risk, analysts should monitor **ad-spend growth rates**, **privacy-law enforcement trends**, and **customer churn** as leading indicators of LiveRamp’s future performance.
For a deeper, data-driven valuation, consider checking ValueRay’s detailed financial model for RAMP.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 68.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 4.56 > 1.0 |
| NWC/Revenue: 53.96% < 20% (prev 56.56%; Δ -2.60% < -1%) |
| CFO/TA 0.14 > 3% & CFO 170.6m > Net Income 68.8m |
| Net Debt (-395.9m) to EBITDA (91.4m): -4.33 < 3 |
| Current Ratio: 2.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.3m) vs 12m ago -4.49% < -2% |
| Gross Margin: 70.40% > 18% (prev 0.72%; Δ 6968 % > 0.5%) |
| Asset Turnover: 64.89% > 50% (prev 58.15%; Δ 6.74% > 0%) |
| Interest Coverage Ratio: 7748 > 6 (EBITDA TTM 91.4m / Interest Expense TTM 10.0k) |
Altman Z'' 10.00
| A: 0.36 (Total Current Assets 679.3m - Total Current Liabilities 250.0m) / Total Assets 1.20b |
| B: 1.16 (Retained Earnings 1.39b / Total Assets 1.20b) |
| C: 0.06 (EBIT TTM 77.5m / Avg Total Assets 1.23b) |
| D: 5.96 (Book Value of Equity 1.41b / Total Liabilities 236.6m) |
| Altman-Z'' Score: 12.81 = AAA |
Beneish M -3.14
| DSRI: 0.92 (Receivables 218.8m/217.2m, Revenue 795.6m/728.7m) |
| GMI: 1.02 (GM 70.40% / 71.77%) |
| AQI: 0.92 (AQ_t 0.43 / AQ_t-1 0.46) |
| SGI: 1.09 (Revenue 795.6m / 728.7m) |
| TATA: -0.08 (NI 68.8m - CFO 170.6m) / TA 1.20b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of RAMP shares?
Over the past week, the price has changed by -3.30%, over one month by -15.05%, over three months by -22.24% and over the past year by -33.45%.
Is RAMP a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RAMP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.5 | 54% |
| Analysts Target Price | 36.5 | 54% |
| ValueRay Target Price | 23.3 | -1.6% |
RAMP Fundamental Data Overview February 08, 2026
P/E Forward = 200.0
P/S = 1.8969
P/B = 1.5226
P/EG = 0.5918
Revenue TTM = 795.6m USD
EBIT TTM = 77.5m USD
EBITDA TTM = 91.4m USD
Long Term Debt = 36.3m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 9.35m USD (from shortTermDebt, last fiscal year)
Debt = 36.3m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -395.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.11b USD (1.48b + Debt 36.3m - CCE 403.4m)
Interest Coverage Ratio = 7748 (Ebit TTM 77.5m / Interest Expense TTM 10.0k)
EV/FCF = 6.56x (Enterprise Value 1.11b / FCF TTM 169.3m)
FCF Yield = 15.25% (FCF TTM 169.3m / Enterprise Value 1.11b)
FCF Margin = 21.27% (FCF TTM 169.3m / Revenue TTM 795.6m)
Net Margin = 8.64% (Net Income TTM 68.8m / Revenue TTM 795.6m)
Gross Margin = 70.40% ((Revenue TTM 795.6m - Cost of Revenue TTM 235.5m) / Revenue TTM)
Gross Margin QoQ = 71.89% (prev 70.18%)
Tobins Q-Ratio = 0.93 (Enterprise Value 1.11b / Total Assets 1.20b)
Interest Expense / Debt = 0.03% (Interest Expense 10.0k / Debt 36.3m)
Taxrate = 7.06% (3.03m / 42.9m)
NOPAT = 72.0m (EBIT 77.5m * (1 - 7.06%))
Current Ratio = 2.72 (Total Current Assets 679.3m / Total Current Liabilities 250.0m)
Debt / Equity = 0.04 (Debt 36.3m / totalStockholderEquity, last quarter 962.3m)
Debt / EBITDA = -4.33 (Net Debt -395.9m / EBITDA 91.4m)
Debt / FCF = -2.34 (Net Debt -395.9m / FCF TTM 169.3m)
Total Stockholder Equity = 950.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.61% (Net Income 68.8m / Total Assets 1.20b)
RoE = 7.23% (Net Income TTM 68.8m / Total Stockholder Equity 950.7m)
RoCE = 7.85% (EBIT 77.5m / Capital Employed (Equity 950.7m + L.T.Debt 36.3m))
RoIC = 7.61% (NOPAT 72.0m / Invested Capital 946.8m)
WACC = 9.68% (E(1.48b)/V(1.51b) * Re(9.92%) + D(36.3m)/V(1.51b) * Rd(0.03%) * (1-Tc(0.07)))
Discount Rate = 9.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 75.99% ; FCFF base≈149.5m ; Y1≈184.4m ; Y5≈314.0m
Fair Price DCF = 68.83 (EV 3.95b - Net Debt -395.9m = Equity 4.34b / Shares 63.1m; r=9.68% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 69.49 | EPS CAGR: 138.0% | SUE: 2.30 | # QB: 2
Revenue Correlation: 97.88 | Revenue CAGR: 11.36% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.56 | Chg30d=+0.002 | Revisions Net=+2 | Analysts=4
EPS next Year (2027-03-31): EPS=2.65 | Chg30d=+0.070 | Revisions Net=+5 | Growth EPS=+18.2% | Growth Revenue=+8.8%